Browsing: itching

Dry eye disease (DED) has become a significant public health issue, affecting millions worldwide. Despite its widespread prevalence, this condition often remains unnoticed and untreated, causing considerable discomfort and potential complications for those who suffer from it. Weitarsa Hendarto, director of PT Combiphar, brings attention to the growing epidemic of said disease and emphasises the need for greater awareness and proactive management. 

Galderma, a global dermatology company, has received filing acceptances for its breakthrough treatment nemolizumab. The drug is designed to treat prurigo nodularis and moderate-to-severe atopic dermatitis in adolescents and adults. It received regulatory nods from authorities in Australia, Singapore, Switzerland, and the United Kingdom via the Access Consortium framework.

Log In or Register as a healthcare professional to read the full article.